Active Chemistry Cells, Biochemistry & Physiology

Modular Helical Foldamers to Drive a Rapid Asymmetric Catalyst Discovery Program

In plain English

AI plain-English summary

Many pharmaceuticals exist as mirror-image molecules, but only one of those two versions actually works in the body—and a new class of helical, modular catalysts aims to make the right version far faster than current methods allow. The problem is that today’s asymmetric catalysts—the tools chemists use to create only the desired handed molecule—are often small, rigid, and difficult to modify. Each catalyst is typically designed for one specific reaction, and its structure limits how many variations chemists can test. This makes discovering an effective catalyst a slow, trial-and-error process. This project builds catalysts that are both helical—giving them an intrinsic handedness—and modular, meaning their functional groups can be swapped in and out easily. Half of the modules are amino acids, which offer a vast range of chemical properties. By simply changing an amino acid, the catalyst’s behaviour can be tuned for a new reaction. If successful, this approach could dramatically speed up catalyst discovery for the pharmaceutical industry, where making the correct molecular hand is essential for drug safety and efficacy. It could also reduce the cost and waste associated with synthesising and testing large numbers of candidate molecules.

View original technical description
Catalysis is central to a wide range of endeavours within industry and academia. Estimated to be worth $433M to the UK economy in 2021 (which enables $188B of revenue in downstream sectors), it is an essential aspect in the pursuit of a sustainable society. Whilst the term 'catalysis' is a broad term that includes for example, the heterogeneous converters in cars, the purification of water, and carbon dioxide capture, a significant part of this field are the homogenous catalyst systems that can provide new ways of creating molecules that have never been made before. Some of these molecules are particularly challenging to make because the only difference between them is that they are mirror images that cannot be superimposed (such as the left and right hands). This phenomenon, known as chirality, has the consequence that differently handed molecules will interact with molecules within the body - which themselves are handed - with different efficacies or effects; think how easy it is to shake someone's right hand (the "biological receptor") with your own right hand (the correctly handed molecule) vs your left hand (the incorrectly handed molecule). This concept within chemistry is specifically known as "asymmetric catalysis" and has clearly an important role in the manufacture of safe and effective pharmaceuticals (an endeavour identified in the 2021 Innovate UK report as being a core benefit of investment). However, the discovery of catalyst systems can be a long process, because they are generally designed to be specific to a single, often fairly niche, reaction process. Many catalytic systems use relatively small molecules to help discriminate between left and right hands of a particular target. Successful catalyst optimisation relies on being able to derivatise those small molecules, which can be severely limited by their molecular structure - often these libraries are very small because there is only one position within the molecule where changes in the molecule can be made. Certainly the functionality within these small molecules - often derived from natural products - cannot be changed easily in either its position or its nature (for example an amine to a carboxylic acid). This proposal seeks to address this by generating highly preorganised catalysts that are modular in nature. There are two very important aspects to that design which give us confidence that this approach will speed up the catalyst discovery process beyond it existing cul-de-sac. First that these catalysts are helical. This means that they are intrinsically "handed" (the mirror image of helices are also non-superimposable) and that the orchestration of reaction processes around them will be highly defined in three-dimensional space (and thus the origin of asymmetry). The second important aspect is that the modularity of these helical scaffolds allows us to swap functionality with ease to whatever is required by the reaction we are trying to catalyse. Half of these modules are amino acids, which make up all of the proteins in our body and thus have a huge range of functionality. For example, we can swap an amine for a carboxylic acid as above by just changing one of the amino acids. We can also modify other aspects of the system very easily, such as the distances between functionalities. This approach will enable vast libraries to be made and will thus impact the catalysis industry in a groundbreaking way.

View the original record at the funder ↗

Researchers

Alexander Cobb (Principal Investigator)Craig Butts (Co-Investigator)Manuel Mueller (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Self-assembly of asymmetric catalysts
A universal catalyst design framework for late-stage functionalisation
ChloroCat - Unlocking metal-chloride bonds for data-driven stereoselective catalysis
An Exploration of Helical Asymmetry - Development and Application of Helical Organocatalysts
Harnessing Electrostatics to Unlock Cage Catalysis: A Combined Experimental Computational Approach

Original classification

Research and Innovation

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.